Cited 0 times in
Hepatitis B virus X protein induced expression of the Nur77 gene.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, MO | - |
dc.contributor.author | Kang, HJ | - |
dc.contributor.author | Cho, H | - |
dc.contributor.author | Shin, EC | - |
dc.contributor.author | Park, JH | - |
dc.contributor.author | Kim, SJ | - |
dc.date.accessioned | 2011-08-08T05:03:51Z | - |
dc.date.available | 2011-08-08T05:03:51Z | - |
dc.date.issued | 2001 | - |
dc.identifier.issn | 0006-291X | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/3703 | - |
dc.description.abstract | Hepatitis B virus (HBV) X protein (HBx) plays an essential role in development of HBV-associated hepatocellular carcinoma (HCC). Recently, we reported that HBx induces Fas Ligand (FasL) expression, which may help HCC cells to evade host-immune surveillance. The aim of this study was to investigate the role of HBx in expression of Nur77, an orphan nuclear receptor implicated in the upregulation of FasL. When Chang X-34 expressing HBx under the control of a doxycycline-inducible promoter was examined, induction of Nur77 was observed following HBx expression. Blocking of Nur77 function by introduction of an antisense or a dominant negative mutant Nur77 significantly inhibited the induction of FasL, indicating that Nur77 plays critical roles in FasL expression. Further, a high-level expression of transcripts and DNA binding of Nur77 were observed in the HBV-integrated cell lines established from HCC patients that express HBx. These results suggested that Nur77 may contribute to leading the HBx-induced Fas/FasL signaling pathway which eliminates invading Fas-expressing lymphocytes. | - |
dc.language.iso | en | - |
dc.subject.MESH | Carcinoma, Hepatocellular | - |
dc.subject.MESH | DNA-Binding Proteins | - |
dc.subject.MESH | Fas Ligand Protein | - |
dc.subject.MESH | Hepatitis B | - |
dc.subject.MESH | Hepatitis B virus | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Liver Neoplasms | - |
dc.subject.MESH | Membrane Glycoproteins | - |
dc.subject.MESH | Mutation | - |
dc.subject.MESH | Nuclear Receptor Subfamily 4, Group A, Member 1 | - |
dc.subject.MESH | Oligonucleotides, Antisense | - |
dc.subject.MESH | Promoter Regions, Genetic | - |
dc.subject.MESH | RNA, Messenger | - |
dc.subject.MESH | Receptors, Cytoplasmic and Nuclear | - |
dc.subject.MESH | Receptors, Steroid | - |
dc.subject.MESH | Trans-Activators | - |
dc.subject.MESH | Transcription Factors | - |
dc.subject.MESH | Transcriptional Activation | - |
dc.subject.MESH | Transfection | - |
dc.subject.MESH | Tumor Cells, Cultured | - |
dc.title | Hepatitis B virus X protein induced expression of the Nur77 gene. | - |
dc.type | Article | - |
dc.identifier.pmid | 11700033 | - |
dc.identifier.url | http://linkinghub.elsevier.com/retrieve/pii/S0006-291X(01)95910-8 | - |
dc.contributor.affiliatedAuthor | 조, 혜성 | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1006/bbrc.2001.5910 | - |
dc.citation.title | Biochemical and biophysical research communications | - |
dc.citation.volume | 288 | - |
dc.citation.number | 5 | - |
dc.citation.date | 2001 | - |
dc.citation.startPage | 1162 | - |
dc.citation.endPage | 1168 | - |
dc.identifier.bibliographicCitation | Biochemical and biophysical research communications, 288(5). : 1162-1168, 2001 | - |
dc.identifier.eissn | 1090-2104 | - |
dc.relation.journalid | J00006291X | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.